Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Darrell 2017 US Patent

From Bioblast
Publications in the MiPMap
Neufer PD, Anderson EJ, Szeto HH (2017) Methods for preventing or treating insulin resistance. US Patent US20170100450 A1.

Β» Open Access

Neufer PD, Anderson EJ, Szeto HH (2017) US Patent

Abstract: The invention provides methods of preventing or treating insulin resistance in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide having at least one net positive charge; a minimum of four amino acids; a maximum of about twenty amino acids; a relationship between the minimum number of net positive charges (pm) and the total number of amino acid residues (r) wherein 3pm is the largest number that is less than or equal to r+1; and a relationship between the minimum number of aromatic groups (a) and the total number of net positive charges (pt) wherein 2a is the largest number that is less than or equal to pt+1, except that when a is 1, pt may also be 1.

β€’ Bioblast editor: Kandolf G β€’ O2k-Network Lab: US NC Greenville Anderson EJ, US NC Greenville Neufer PD


Labels: MiParea: Respiration  Pathology: Diabetes, Obesity 

Organism: Human, Rat  Tissue;cell: Skeletal muscle  Preparation: Permeabilized tissue 


Coupling state: LEAK, OXPHOS  Pathway: F, N, S, ROX  HRR: Oxygraph-2k 

Labels